Heterozygosity for p53 promotes microsatellite instability and tumorigenesis on a Msh2 deficient background.

Abstract:

:In colorectal tumorigenesis, loss of function of the mismatch repair genes is closely associated with genomic instability at the nucleotide level whereas p53 deficiency has been linked with gross chromosomal instability. We have addressed the contribution of these two forms of genetic instability to tumorigenesis using mice mutant for Msh2 and p53. As previously reported, deficiency of both genes leads to rapid lymphomagenesis Here we show that heterozygosity for p53 also markedly reduces survival on an Msh2 null background. We characterized the patterns of genomic instability in a small set of tumours and showed that, as predicted p53 deficiency predisposes to aneuploidy and Msh2 deficiency leads to microsatellite instability (MSI). However, heterozygosity for p53 in the absence of Msh2 resulted in increased MSI and not aneuploidy. This implied role for p53 in modulating MSI was confirmed using a large cohort of primary fibroblast clones. The differences observed were highly significant (P<0.01) in both the fibroblast clones (which all retained p53 functionality) and the tumours, a proportion of which retained p53 functionality. Our results therefore demonstrate a dose sensitive role for p53 in the maintenance of genomic integrity at the nucleotide level.

journal_name

Oncogene

journal_title

Oncogene

authors

Toft NJ,Curtis LJ,Sansom OJ,Leitch AL,Wyllie AH,te Riele H,Arends MJ,Clarke AR

doi

10.1038/sj.onc.1205727

subject

Has Abstract

pub_date

2002-09-12 00:00:00

pages

6299-306

issue

41

eissn

0950-9232

issn

1476-5594

journal_volume

21

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate.

    abstract::Recent genome analysis of human prostate cancers demonstrated that both AR gene amplification and TP53 mutation are among the most frequently observed alterations in advanced prostate cancer. However, the biological role of these dual genetic alterations in prostate tumorigenesis is largely unknown. In addition, there...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0901-8

    authors: He Y,Johnson DT,Yang JS,Wu H,You S,Yoon J,Lee DH,Kim WK,Aldahl J,Le V,Hooker E,Yu EJ,Geradts J,Cardiff RD,Sun Z

    更新日期:2019-09-01 00:00:00

  • THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.

    abstract::Promyelocytic leukemia (PML) nuclear bodies (PML NBs) are discrete subnuclear domains organized by the promyelocytic leukemia protein PML, a tumor suppressor essential for multiple apoptotic pathways. We have recently described a novel family of cellular factors, the THAP proteins, characterized by the presence at the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206271

    authors: Roussigne M,Cayrol C,Clouaire T,Amalric F,Girard JP

    更新日期:2003-04-24 00:00:00

  • PCR-based identification of new receptors: molecular cloning of a receptor for fibroblast growth factors.

    abstract::Transmembrane tyrosine kinases are involved in the control of cell growth and differentiation by extracellular signals. To enable identification of new receptor tyrosine kinases we developed a method that selectively amplifies segments of receptor genes. The method is based on a combination of polymerase chain reactio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Raz V,Kelman Z,Avivi A,Neufeld G,Givol D,Yarden Y

    更新日期:1991-05-01 00:00:00

  • And-1 is required for the stability of histone acetyltransferase Gcn5.

    abstract::Histone acetyltransferases (HATs) have a central role in the modification of chromatin as well as in the pathogenesis of a broad set of diseases including cancers. Gcn5 is the first identified transcription-related HAT that has been implicated in the regulation of diverse cellular functions. However, how Gcn5 proteins...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.261

    authors: Li Y,Jaramillo-Lambert AN,Yang Y,Williams R,Lee NH,Zhu W

    更新日期:2012-02-02 00:00:00

  • Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation.

    abstract::Silencing of gene expression by methylation of CpG islands in regulatory elements is frequently observed in cancer. However, an influence of the most common oncogenic signalling pathways onto DNA methylation has not yet been investigated thoroughly. To address this issue, we identified genes suppressed in HRAS-transfo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209502

    authors: Lund P,Weisshaupt K,Mikeska T,Jammas D,Chen X,Kuban RJ,Ungethüm U,Krapfenbauer U,Herzel HP,Schäfer R,Walter J,Sers C

    更新日期:2006-08-10 00:00:00

  • The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.

    abstract::Fli-1 is a proto-oncogene which is rearranged in tumors induced by three different retroviruses, Cas-Br-E, F-MuLV, and 10A1. This gene is a member of the Ets gene family, a class of transcription factors that recognize and bind to a DNA motif known as the Ets binding site (EBS). Our laboratory has previously cloned an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202913

    authors: Barbeau B,Barat C,Bergeron D,Rassart E

    更新日期:1999-09-30 00:00:00

  • A RAS-CaMKKβ-AMPKα2 pathway promotes senescence by licensing post-translational activation of C/EBPβ through a novel 3'UTR mechanism.

    abstract::Oncogene-induced senescence (OIS) is an intrinsic tumor suppression mechanism that requires the p53 and RB pathways and post-translational activation of C/EBPβ through the RAS-ERK cascade. We previously reported that in transformed/proliferating cells, C/EBPβ activation is inhibited by G/U-rich elements (GREs) in its ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0190-7

    authors: Basu SK,Gonit M,Salotti J,Chen J,Bhat A,Gorospe M,Viollet B,Claffey KP,Johnson PF

    更新日期:2018-06-01 00:00:00

  • TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation.

    abstract::The p14ARF tumor suppressor is a key regulator of cellular proliferation, frequently inactivated in human cancer. The mechanisms that regulate alternative reading frame (ARF) turnover have been obscure for long time, being ARF a relatively stable protein. Recently, it has been described that its degradation depends, a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210313

    authors: Pollice A,Sepe M,Villella VR,Tolino F,Vivo M,Calabrò V,La Mantia G

    更新日期:2007-08-02 00:00:00

  • A retroviral library genetic screen identifies IRF-2 as an inhibitor of N-ras-induced growth suppression in leukemic cells.

    abstract::Activating mutations of the N-ras gene occur at relatively high frequency in acute myeloid leukemia and myelodysplastic syndrome. Somewhat paradoxically, ectopic expression of activated N-ras in primary hematopoietic cells and myeloid cell lines (in some cases) can lead to inhibition of proliferation. Expression of mu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208877

    authors: Passioura T,Shen S,Symonds G,Dolnikov A

    更新日期:2005-11-10 00:00:00

  • Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling.

    abstract::The hyperactivated Wnt/β-catenin signaling acts as a switch to induce epithelial to mesenchymal transition and promote colorectal cancer. However, due to its essential role in gut homeostasis, therapeutic targeting of this pathway has proven challenging. Additionally, IL-6/Stat-3 signaling, activated by microbial tran...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.259

    authors: Ahmad R,Kumar B,Chen Z,Chen X,Müller D,Lele SM,Washington MK,Batra SK,Dhawan P,Singh AB

    更新日期:2017-11-23 00:00:00

  • Targeting CK2-driven non-oncogene addiction in B-cell tumors.

    abstract::Genetic mutations of oncogenes often underlie deranged cell growth and altered differentiation pathways leading to malignant transformation of B-lymphocytes. However, addiction to oncogenes is not the only drive to lymphoid tumor pathogenesis. Dependence on non-oncogenes, which act by propelling basic mechanisms of ce...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.86

    authors: Mandato E,Manni S,Zaffino F,Semenzato G,Piazza F

    更新日期:2016-11-24 00:00:00

  • Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.

    abstract::The molecular basis for the resistance of tumor cells to cell-mediated cytotoxicity remains poorly understood and thus poses a major challenge for cancer immunotherapy. The present study was designed to determine whether the WNT1-inducible signaling pathway protein 2 (WISP2, also referred to as CCN5), a key regulator ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.151

    authors: Akalay I,Tan TZ,Kumar P,Janji B,Mami-Chouaib F,Charpy C,Vielh P,Larsen AK,Thiery JP,Sabbah M,Chouaib S

    更新日期:2015-04-23 00:00:00

  • MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness.

    abstract::The tumor microenvironment plays a critical role in prostate cancer (PC) development and progression. Inappropriate activation of the stroma potentiates the growth and transformation of epithelial tumor cells. Here, we show that upregulation of monoamine oxidase A (MAOA), a mitochondrial enzyme that degrades monoamine...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1217-4

    authors: Li J,Pu T,Yin L,Li Q,Liao CP,Wu BJ

    更新日期:2020-04-01 00:00:00

  • Structure and function of Polo-like kinases.

    abstract::Polo-like kinases play critical roles during multiple stages of cell cycle progression. All Polo-like kinases contain an N-terminal Ser/Thr kinase catalytic domain and a C-terminal region that contains one or two Polo-boxes. For Polo-like kinase 1, 2, and 3, and their homologs, the entire C-terminal region, including ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1208280

    authors: Lowery DM,Lim D,Yaffe MB

    更新日期:2005-01-10 00:00:00

  • Modulation of Nr-13 antideath activity by peptide aptamers.

    abstract::Tumor cells are characterized by deregulated proliferation and resistance to proapoptotic stimuli. The Bcl-2 family of antiapoptotic proteins is overexpressed in a large number of chemoresistant tumors. Downregulation or inhibition of antiapoptotic proteins might result in the sensitization of cancer cells to chemothe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209832

    authors: Nouvion AL,Thibaut J,Lohez OD,Venet S,Colas P,Gillet G,Lalle P

    更新日期:2007-02-01 00:00:00

  • Therapeutic approaches to AIDS-related malignancies.

    abstract::The introduction of highly active antiretroviral therapy (HAART) has changed dramatically the landscape of HIV disease. Deaths from AIDS-related diseases have been reduced by 75% since protease inhibitor therapy and combination antiretroviral therapy came into use in late 1995. While KS is declining, the situation for...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206771

    authors: Berretta M,Cinelli R,Martellotta F,Spina M,Vaccher E,Tirelli U

    更新日期:2003-09-29 00:00:00

  • The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells.

    abstract::The cytoplasmic tyrosine kinase Src has been implicated in signal transduction induced by growth factors and integrins. Src also shows oncogenic activity when deregulated. Accumulating evidence indicates that the tyrosine kinase Abl is an important substrate for Src signalling in normal cells. Here we show that Abl is...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210543

    authors: Sirvent A,Boureux A,Simon V,Leroy C,Roche S

    更新日期:2007-11-15 00:00:00

  • Males absent on the first (MOF): from flies to humans.

    abstract::Histone modifications such as acetylation, methylation and phosphorylation have been implicated in fundamental cellular processes such as epigenetic regulation of gene expression, organization of chromatin structure, chromosome segregation, DNA replication and DNA repair. Males absent on the first (MOF) is responsible...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210607

    authors: Rea S,Xouri G,Akhtar A

    更新日期:2007-08-13 00:00:00

  • Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer.

    abstract::Acquired therapeutic resistance is the major drawback to effective systemic therapies for cancers. Aggressive triple-negative breast cancers (TNBC) develop resistance to chemotherapies rapidly, whereas the underlying mechanisms are not completely understood. Here we show that genotoxic treatments significantly increas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.189

    authors: Niu J,Xue A,Chi Y,Xue J,Wang W,Zhao Z,Fan M,Yang CH,Shao ZM,Pfeffer LM,Wu J,Wu ZH

    更新日期:2016-03-10 00:00:00

  • Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25.

    abstract::Chromosome 17 is one of the most frequently altered chromosomes in malignant breast cancer. At least four genes implicated in breast cancer reside on chromosome 17 (p53, 17p13; Her-2/neu/ERBB2, 17q12; BRCA1, 17q21; and nm23, 17q22). In addition, allelic imbalance has been described for at least five regions of chromos...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201073

    authors: Plummer SJ,Adams L,Simmons JA,Casey G

    更新日期:1997-05-15 00:00:00

  • TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.

    abstract::Tumor suppressor p53 has been shown to repress expression of vascular endothelial growth factor (VEGF), an endothelial cell-specific mitogen and a key mediator of tumor angiogenesis. The p63 gene, recently identified as a p53-relative, encodes multiple isoforms with structural and functional similarities and differenc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205330

    authors: Senoo M,Matsumura Y,Habu S

    更新日期:2002-04-11 00:00:00

  • Genetic instability: tipping the balance.

    abstract::Tumor cells typically contain a genome that is highly divergent from the genome of normal, non-transformed cells. This genetic divergence is caused by a number of distinct changes that the tumor cell acquires during its transformation from a normal cell into a tumorigenic counterpart. Changes to the genome include mut...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2012.576

    authors: Janssen A,Medema RH

    更新日期:2013-09-19 00:00:00

  • Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression.

    abstract::Non small cell lung cancer (NSCLC) is the leading cause of cancer deaths in the United States and worldwide. Unfortunately, standard therapies remain inadequate. An increased understanding of the molecular biology of lung cancer biology is required to develop more effective new therapies. In this report, we show that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206817

    authors: Uematsu K,He B,You L,Xu Z,McCormick F,Jablons DM

    更新日期:2003-10-16 00:00:00

  • ALDH1L1 inhibits cell motility via dephosphorylation of cofilin by PP1 and PP2A.

    abstract::Here we report that ALDH1L1 (FDH, a folate enzyme with tumor suppressor-like properties) inhibits cell motility. The underlying mechanism involves F-actin stabilization, re-distribution of cytoplasmic actin toward strong preponderance of filamentous actin and formation of actin stress fibers. A549 cells expressing FDH...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.356

    authors: Oleinik NV,Krupenko NI,Krupenko SA

    更新日期:2010-11-25 00:00:00

  • PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia.

    abstract::The p53 tumour suppressor is involved in several crucial cellular functions including cell-cycle arrest and apoptosis. p53 stabilization occurs under hypoxic and DNA damage conditions. However, only in the latter scenario is stabilized p53 capable of inducing the expression of its pro-apoptotic targets. Here we presen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.192

    authors: Xenaki G,Ontikatze T,Rajendran R,Stratford IJ,Dive C,Krstic-Demonacos M,Demonacos C

    更新日期:2008-10-02 00:00:00

  • Methyltransferase inhibition induces p53-dependent apoptosis and a novel form of cell death.

    abstract::We have analysed the importance of proper substrate methylation by S-adenosylmethionine-dependent methyltransferases for cell survival and cell cycle progression. We show that treatment of cells with the methyltransferase inhibitor adenosine dialdehyde (AdOx) causes cell cycle arrest and death in different cell types....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208855

    authors: Schwerk C,Schulze-Osthoff K

    更新日期:2005-10-27 00:00:00

  • The stem cell transcription factor ZFP57 induces IGF2 expression to promote anchorage-independent growth in cancer cells.

    abstract::Several common biological properties between cancer cells and embryonic stem (ES) cells suggest the possibility that some genes expressed in ES cells might have important roles in cancer cell growth. The transcription factor ZFP57 is expressed in self-renewing ES cells and its expression level decreases during ES cell...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.599

    authors: Tada Y,Yamaguchi Y,Kinjo T,Song X,Akagi T,Takamura H,Ohta T,Yokota T,Koide H

    更新日期:2015-02-05 00:00:00

  • Immortalization and transformation of human fibroblasts by regulated expression of polyoma virus T antigens.

    abstract::We have established conditions for the immortalization of human fibroblasts by the large T antigen of the rodent virus polyoma. This allows the mechanism of immortalization to be studied, without interference by transformation events, in cells with relatively stable chromosomes. Large T antigen could immortalize human...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Strauss M,Hering S,Lubbe L,Griffin BE

    更新日期:1990-08-01 00:00:00

  • Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression.

    abstract::Sex-determining region Y box 6 (SOX6) has been described as a tumor-suppressor gene in several cancers. Our previous work has suggested that SOX6 upregulated p21(Waf1/Cip1)(p21) expression in a p53-dependent manner; however, the underlying mechanism has remained elusive. In this study, we confirmed that SOX6 can suppr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.234

    authors: Wang J,Ding S,Duan Z,Xie Q,Zhang T,Zhang X,Wang Y,Chen X,Zhuang H,Lu F

    更新日期:2016-03-31 00:00:00

  • TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells.

    abstract::Genomic instability is a hallmark feature of cancer cells, and can be caused by defective DNA repair, for instance due to inactivation of BRCA2. Paradoxically, loss of Brca2 in mice results in embryonic lethality, whereas cancer cells can tolerate BRCA2 loss. This holds true for multiple DNA repair genes, and suggests...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0470-2

    authors: van Gijn SE,Wierenga E,van den Tempel N,Kok YP,Heijink AM,Spierings DCJ,Foijer F,van Vugt MATM,Fehrmann RSN

    更新日期:2019-02-01 00:00:00